Privately held; Founded in 2020
1 - 5 employees
1 followers
There are no other requests for proposal from Mira Life Science Ventures
An new alternative to traditional venture investment into early-stage life science innovation - Highly flexible corporate structure with broad investment capabilities, no restrictions. Can invest in companies, in-license patents, incubate technology, innovate, and collect royalties – a compelling alternative to traditional venture funds and private equity - Broad and diverse access to opportunities - Highly experienced management team- long history of product invention and development - Investor/Shareholder focused while providing “Evergreen” returns - Management does not take a guaranteed 2% management fee or a 20% carry, off-the-top, on revenues before investor/shareholder distributions - Previous Fund Management experience: 13 years, 22% IRR, 80x return on original capital
Investor type
Investing as asset owner (own investment)
Asset class
Private capital
Investment vehicle
Investment region
Investment focus
Investment process
Trading/liquidity type
Selected dividend policy should be
Reinvesting, Distributing
Tax reporting
United Kingdom, United States
The investment should be available for
Qualified/accredited investor from: Switzerland, Germany, France, United Kingdom, United States, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Türkiye, Ukraine, United Arab Emirates NonQualified/retail investor from: Switzerland, Germany, France, United Kingdom, United States, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Türkiye, Ukraine, United Arab Emirates
Retrocessions
Both possible